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*dm This study examined Ike association between the
presence of tricuspid regurgitation and immediate and late ad-
verse outcomes in patients
undergoing balloon mitral valvulo-
phuty.
Bac& m J Significant tricuspid regurgitation has an adverse
Impact on morbidity and mortality
it,
patients
undergoing mitral
valve surgery for nitral stenosis .
IFetiteds. We studled 318 consecutive patients (mean [*SD]
age 54 t 15 yarn) who underwent balloon mitral valvuloplasty
and had color Doppler echocardlographic studies before the
procedure.
Patients were classified into three groups : 221 with no
or mild (0%),
60 with moderate (19%) and 37 with severe (12%)
tricuspid r
"urg
itation. Clinical follow-up ranged from 6 to 62
months.
Resatds
. Before mitral valvuloplasty, Increasing degrees of
tricuspid regurgitation were associated with a smaller initial
mitral valve area (p < 0.05), higher echocardiegraphic score (p
<
0
.05), lower cardiac output
(p
<
0.01) and higher pulmonary
Severe mitral stenosis is frequently associated with significant
tricuspid regurgitation (1-5) . Retrospective studies (5-10)
have indicated that significant residual tricuspid regurgitation
after mitral valve surgery is associated with increased morbid-
ity and mortality
. As a consequence, it has become surgical
practice to correct significant residual tricuspid regurgitation at
the time of mitral valve surgery, especially after the introduc-
tion of the DeVega annuloplasty technique with its favorable
results (6,11,12).
Recently, percutaneous mitral balloon valvuloplasty has
become an accepted alternative to surgery for the treatment of
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vascular resistance (p < 0 .01) . Although the initial success rate
did not direr significantly between groups, patients with a higher
degree or tricuspid regurgitation had less optimal results, as
reflected by
a smaller absolute increase in mitral valve area (1 .02
vs. 0.9 vs. 0.7 cm2, p < 0.01). The estimated 4-year event-free
survival rate (freedom from death, mitral valve surgery, repeat
valvuloplasty and heart failure) was lower for the group with
severe tricuspid regurgitation (68% vs . 58% vs
. 35%, p < 0
.0001) .
At 4 years, 94% of patients with mild tricuspid regurgitation were
alive compared with 90m and 69%, respectively, of patients with
moderate or severe tricuspid regurgitation (p < 0 .0001)
. Cox
proportional analysis Identified tricuspid regurgitation as an
independent predictor of late outcome (p < 0.001) .
Conclusions, Patients with mitral stenosis and severe tricuspid
regurgitation undergoing mitral vahuloplasty have advanced mi-
tral valve and pulmonary vascular disease, suboptimal immediate
results and poor late outcome.
(J Am Coll Cardiol 1994;24:696-702)
mitral stenosis (13,14) . Although attractive in many respects,
this new technique has the potential disadvantage that residual
tricuspid regurgitation may persist after the procedure, espe-
cially when the lesion has contributed to irreversible right heart
dilation or is of organic origin .
Because of these concerns, we evaluated the association
between the presence of tricuspid regurgitation before mitral
valvuloplasty and immediate and long-term adverse outcomes
in patients with different degrees of tricuspid regurgitation who
underwent balloon mitral valvuloplasty at our institution over
a period of 5 years.
Methods
Study group. We studied a total of 318 consecutive patients
(251 women [75%1, 67 men
; mean [±SDI age 54 ± 15 years,
range 20 to 85) who underwent balloon mitral valvuloplasty
from December 1987 to January 1993 and had color Doppler
echocardiographic studies performed at our institution before
balloon mitral valvuloplasty
. Clinical characteristics of the
study group are presented in Table 1 . On the basis of color
Doppler echocardiographic grading of tricuspid regurgitation
(see later), patients were classified into three groups
: 221
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regurgitation was evaluated with cine left ventriculography,
and its severity was graded from I + to 4+, as described
previously (16)
.
Echocardiographic analysis . A complete two-dimensional
and Doppler color flow echocardiographic examination was
performed <24 h before balloon mitral valvuloplasty using a
Hewlett-Packard 77 2 A ultrasound imager equipped with a
2.5-MHz phased array transducer . Standard echocardiographic
images were obtained. A previously described semiquantitative
echocardiographic assessment of mitral valve score (17) was
obtained in each patient by assigning values of
to 4 (with
increasing abnormality) to each of four morphologic charac-
teristics of the valve : leaflet mobility, thickening, calcification
and subvalvular thickening (score range (1 to 16) .
Assessment of severity of tricuspid regtugitatiou . Tricuspid
regurgitation was routinely assessed by integrating both Dopp-
ler color flow mapping images of the regurgitant jet and pulsed
wave Doppler evidence of systolic flow reversal in the inferior
vena cava or hepatic veins (18) . Careful Doppler evaluation of
the jet was performed in all obtainable views of the right
ventricle and atrium, including the parasternal short-axis view
at the aortic valve level, the right ventricular inflow view, the
apical four-chamber view and subcostal views . The color flow
mapping display of reversed or mosaic signals originating from
the tricuspid valve and extending into the right atrium during
systole identified the presence of tricuspid regurgitation . The
narrowest sector angle encompassing the regurgitant jet was
used to obtain maximal frame rate . The area of disturbed flow
that was traced (using a Sony off-line analysis system) included
the aliased signals as well as the immediately contiguous
nonturbulent velocities moving in the same direction as the jet .
Planimetry was performed only if maximal jet area was visually
estimated to be more than a minimal 1 % of the right atrial
area; it was performed in 114 patients . Right atrial area was
traced from the same frame as the maximal jet area .
Tricuspid regurgitation was then graded as mild, moderate
or severe according to the following algorithm . 1) The view was
selected in which the spatial distribution of the jet was maxi-
mal. 2) The severity of regurgitation was graded as mild if the
jet area was estimated to occupy <2
% of the right atrial area,
as moderate if this value was between 2 % and 33% and as
severe if it was >33%, based on correlations with surgical and
angiographic severity in previous studies (19-21)
. 3) If the
estimated ratio of jet area to right atrial area was close to a
cutoff point, jet eccentricity increased the grade above that
cutoff point to the next higher grade (22,23) because eccentric
wall jets appear smaller than comparable free jets . 4) Systolic
flow reversal in the inferior vena cava or hepatic veins by
pulsed wave Doppler echocardiography was considered to
indicate at least moderate regurgitation regardless of the other
findings (2
)
. Tricuspid regurgitation was defined as organic if
there was thickening, doming or restricted motion of the valve
leaflets .
Clinical follow-up. Clinical follow-up ranged from 6 to 62
months (mean 26.7 ± 18 .4) . Data were obtained during patient
visits to clinic or by telephone interviews conducted by a
Data are presented as mean value SI) or number (''i ) of patients . NYI IA
class = New York Ileart Association functional class .
(69%) with no or mild, 6
(19%) with
with severe tricuspid regurgitation .
Cardiac catheterization. All patients underwent balloon
mitral valvuloph.d~y ' y the transseptal approach . Complete
right and left heart catheterization and oximetry studies were
performed before and after balloon mitral valvuloplasty to
evaluate the changes in hemodynamic variables produced by
balloon mitral valvuloplasty and the presence and degree of
left to right shunting through the created atrial communica-
tion. Blood samples were obtained from the superior vena
cava, pulmonary artery and aorta before and after the proce-
dure in all patients. Left to right shunting through the created
atrial communication was diagnosed when there was a ?7%
step-up between superior vena cava and pulmonary artery
samples in repeated samples . Significant tricuspid regurgita-
tion was diagnosed by clinical, Doppler echocardiographic and
hemodynamic findings.
Cardiac output was measured using the thermodilution
technique in patients without or with only mild tricuspid
regurgitation. In the patients with significant (moderate or
severe) tricuspid regurgitation or a left to right shunt, or both,
cardiac output was measured by using the Fick principle . In the
presence of tricuspid regurgitation, pulmonary artery satura-
tion was used as mixed sample in the calculation of cardiac
output. The superior vena cava saturation was used as mixed
sample when a left to right shunt across the created atrial
communication was present . Oxygen consumption was mea-
sured using an MRM-2 oxygen consumption monitor (Waters
Instrument Inc .) . Mitral valve area was determined using the
Gorlin formula (15). Successful balloon mitral valvuloplasty
was defined as a final mitral valve area ? 1 .5 em2 or a >5
%
increase in area after the procedure, with a ~2+ grade
increase in mitral regurgitation and a left to right shunt
(pulmonary/systemic flow ratio <1
.5 :1) . The double-balloon
technique was used almost exclusively (n = 3
2). Mitral
moderate and 37 (12%)
Table 1 . Baseline Characteristics of 318 Study Patients
Age (yr) 54 *_ IS
Female patients 251(75%)
NYHA class
III 2 9 (66%i:)
IV 26 (K% )
Sinus rhythm 155 (49'(")
Atrial fibrillation 163 (51 %la)
Previous commissurotomy 58(18%)
Mitral valve score 7 .4 ± 2 .1
Mitral regurgitation
None 17
(53%)
Mild 129 (4 4 )
Moderate 19 (7%)
Tricuspid regurgitation
Mild 221 (69%)
Moderate 611(19`-?')
Severe 37 (12%)
Organic 11 (3''?•)
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trained nurse or cardiologist with the referring physician, the
Table 2. Clinical and Morphologic Characteristics of the Study
patients, or both. The clinical end points used in this study
included 1) mitral valve surgery (valve replacement or repair),
2) repeat balloon mitral valvuloplasty, 3) development of
symptomatic heart failure (New York Heart Association func-
tional class III or IV, and 4) death . Causes of death were
evaluated from data provided by the patient's physician or
medical records.
Data aaalysls. Data are expressed as mean value ± SD ; a
p value < . 5 was considered significant . All analyses were
performed with use of RS1 statistical software (BBN software
product) and the survival analysis program BMDP statistical
software package . The three groups were compared by using
one-way analysis of variance for continuous variables . If no
significant difference was detected, no further subgroup anal-
yses were performed . When a significant difference was found,
then subsequent to the analyses of variance planned compar-
isons were conducted to examine differences between individ-
ual pair of groups (mild vs . moderate, moderate vs . severe and
mild vs. severe). This technique protects against spurious
significant differences due to multiple comparisons (24). Chi-
square analysis was used to compare proportions of patients on
the basis of discrete variables . The Fisher exact test was used
when all expectations were too small. Kaplan-Meier estimates
(25) were used to determine event-free survival (defined as the
absence of all four end points defined earlier) . The Mantel-
Cox test statistic available in BMDP IL program was used to
compare survival curves among groups. Multiple stepwise Cox
regression analysis (26) was performed to identify independent
predictors of event-free survival . Two separate analyses were
performed . The first included only baseline (preprocedural)
variables : age, gender, transmittal valve gradient, cardiac out-
put, mitral valve area, left atrial pressure, mean pulmonary
pressure, pulmonary artery resistance, mitral regurgitation,
fluoroscopic presence of calcium, cardiac rhythm, echocardio-
graphic score, functional class and history of previous commis-
surotomy. The second model included these variables as well
as postprocedural hemodynamic variables, such as final mitral
valve area and transmitral pressure gradient. The hazard ratios
from the Cox analysis were used to estimate relative risk.
Multiple stepwise logistic regression analysis was used to
identify independent predictors for initially successful balloon
mitral valvuloplasty .
Results
Preprocederal clinical, morphologic and hemodynamic
characterist cs . Important clinical, morphologic and hemody-
namic variables measured before the procedure in the three
groups are shown in Tables 2 and 3
. A higher grade of tricuspid
regurgitation was associated with a higher incidence of anal
fibrillation and significantly worse functional class before the
procedure
. Mean right atrial pressure was significantly higher
in those patients with severe versus moderate or mild tricuspid
regurgitation (11.8 ± 5.3 vs . 8 .5 ± 4.7 vs. 6.7 ± 3.4 mm Hg,
p < . 4) .
Group Before Balloon Mitral Valvuloplasty
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'p < . 1 versus mild. tp < . 1 versus moderate. tp < . 5 versus mild.
§p <
. 5 versus moderate. Data presented are mean value ± SD or number (Se)
of patients . NYHA class = New York Heart Association functional class .
Increasing degrees of tricuspid regurgitation corresponded
to smaller initial mitral valve area (.96 cm2 for mild vs. .8 cm2
for moderate vs. .85 cm 2 for severe tricuspid regurgita(ion, p <
. 5 for mild vs. severe tricuspid regurgitation), higher echocar-
diographic score (7.1 vs. 7.8 vs . 8.7, p < . 5), lower cardiac
output (4.1 vs. 3.5 vs. 3.4 liters/min, p < . 1) and higher
pulmonary vascular resistance (223 vs. 3 1 vs. 387 dyncs'mm
..
5,
p < . 1) .
Immediate results. Percutancous balloon mitral valvulo-
plasty resulted in substantial increases in mitral valve area
(from .93 ± .3 to 1 .9 ± .8 cm). Final mitral valve area 2 :1 .5
was achieved in 227 patients (72%). The overall initial success
rate by the criteria defined earlier was 79% and did not differ
significantly for the mild (81%), moderate (77%) and severe
tricuspid regurgitation (76%) groups . However, the absolute
increase in calculated mitral valve area was greater in subjects
with mild versus moderate versus severe tricuspid regurgitation
(1 . 2 ± .7, .91 ± .5 and .7 ± .5 cm 2, respectively, p < . 1
for mild vs . severe tricuspid regurgitation groups) . The hemo-
dynamic findings after balloon mitral valvotomy are listed in
Table 4. The decrease in transmittal gradient was significantly
higher in the group with mild tricuspid regurgitation than in
the groups with moderate or severe regurgitation (9 .1 vs. 7.3
vs. 6 .9 mm Hg, respectively, p < . 1). The final transmitral
pressure gradient, mean pulmonary artery pressure and pul-
Table 3. Hemcxlynainic Variables Before Balloon Mitral
Valvuloplasty in Patients With Mild, Moderate or Severe
Tricuspid Regurgitation
'p < . 5 versus mild. tp < . 1 versus mild. Data presented are mean value
± SD. IA = left atrial ; PAP = pulmonary artery pressure ; PVR = pulmonary
vascular resistance .
Tricuspid Regurgitation
Mild Moderate Severe
Age (yr) 53 ± 14 58 ± 14* 62 *_ 16
NYHA class III or IV 153(69%) 52(87%)' 311 (8l io)'
Atrial fibrillation 94(43%) 39(7 %)' 3 (81%)1'
Mitral regurgitation
Mild 77 (35%'r,) 27(45%) 16(4.3%)
Moderate 9(4%) 3(5%) 6(16%)t
Mitral valve score 7.1±2 7.8 ± 2 .2t 8 .1± 1 A§
Tricuspid Regurgitation
Mild Moderate Severe
Mitral gradient (mm Hg) 14.3±6 .1 12.7±5 .1 12.8 ± 5.2
to pressure (mm Hg) 24 .7 ± 9 .5 24. ± 6 .9 255±5.7
Mitral valve area (cm) .96± .3 .86± .3' .85± .3'
Mean PAP (mm Hg) 35*_11 .4 36. ±11 .6 411.4±13 .9'
PVR (dynesscm -`) 223 ± 197 3 1 ± 234t 387 ± 357'
Cardiac output (liters/min) 4.1 ± 1.1 35± .9t 3.4± .9t
monary vascular resistance were higher in the moderate and
severe regurgitation groups than in the mild regurgitation
group, whereas the final mitral valve area and cardiac output
were significantly lower for the severe versus the mild tricuspid
regurgitation group.
Clinical follow-up. Follow-up data were available for 3 7
(97%) of the 318 patients. The probability of event-free
survival (freedom from death, mitral valve surgery, repeat
balloon mitral valvuloplasty and symptomatic heart failure)
was significantly lower for the severe tricuspid regurgitation
group (Fig . 1) . At 1 year of follow-up the event-free survival
rate was 84%, 74% and 61%, respectively, for the mild,
moderate and severe tricuspid regurgitation groups . At 4 years
the rate was 68%, 58% and 35%, respectively (p < . 1 for
mild vs. severe tricuspid regurgitation). A total of 2 deaths
had occurred a mean of 39 ± 12 months after balloon mitral
valvuloplasty ; 18 deaths were from cardiac causes, 1 was due to
lung cancer and 1 had -to known cause . At 4 years 94% of
patients with mild tricuspid regurgitation were alive compared
with 9 % and 69%, respectively, of patients with moderate or
severe tricuspid regurgitation (p < . 1 for mild vs . severe
tricuspid regurgitation groups [Fig . 2]) . The mortality rate
before mitral valve surgery at last contact was significantly
lower in the mild versus moderate versus severe tricuspid
regurgitation groups (4% vs . 8% vs. 19%, respectively, p <
Figure 1. Kaplan-Meicr estimates of event-free survival rate after
balloon mitral valvuloplasty among 318 patients with mild, moderate
or severe tricuspid regurgitation (TR). Events were defined as mitral
valve surgery, repeat balloon valvuloplasty, New York Heart Associa-
tion functional class III or IV and death before mitral valve surgery .
. 2 for mild v, severe tricuspid regurgitation) . The need for
mitral valve surgery or repeat balloon mitral valvuloplasty was
higher for the severe tricuspid regurgitation group, but these
differences did not reach statistical significance involving 45
(2 %),13 (22%) and 11(3 %) of patients with mild, moderate
or severe tricuspid regurgitation, respectively . Freedom from
symptomatic heart failure (functional class III or IV) was
greater for the mild tricuspid regurgitation group ; at 4 years,
97% of patients with mild tricuspid regurgitation were free
from symptomatic heart failure compared with 94% and 88%,
respectively, of patients with moderate or severe tricuspid
regurgitation (p < . 4 for mild vs . severe tricuspid regurgita-
tion) .
Predictors of event-free survival . Stepwise multivariate
Cox regression analysis of baseline variables identified tricus-
pid regurgitation as an independent predictor of long-term
event-free survival (p < . 5). The importance of each
predictor, relative risks and statistical significance are pre-
sented in Table 5. Increase in tricuspid regurgitation grade
from mild to severe was associated with a net 1 .7-fold increase
in the risk for adverse end point (an increase by a factor of
1 .3/grade) (1 .3 2 for an increase of two grades) . Other indepen-
dent preprocedural predictors were previous commissurotomy,
functional class, mitral regurgitation and echocardiographic
mitral valve score (p < . 5 for all variables). Increase in
mitral valve score over the usual range from 4 to 12 was
associated with a 2.1-fold increased risk for adverse outcome
.
When postprocedural variables (final mitral valve area and
Table 5. Summary of Cox Regression Analyses for Late Outcome
After Percutaneous Balloon Mitral Valvuloplasty
*An increase in one grade of tricuspid regurgitation, mitral regurgitation and
New York Heart Association (NYHA) functional class, or an increase in
1 unit
(of 16) of
mitral valve score or a history of previous commissurotomy is
associated with the relative risk indicated .
Relative
Risk' p Value
Tricuspid regurgitation group 1 .3
. 5
NYHA class 1 .5
. 5
Mitral regurgitation grade 1 .7
. 5
Mitral valve score 1 .1
. 5
Previous commissurotomy
1 .6
. 5
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Table 4. Hemodynamic Variables of the Study Group After Balloon
1 % .
2
Mitral Valvuloplasty
8 %
Tricuspid Regurgitation
® 6 %
Mild Moderate Severe
5 .1
± 2.6 5 .5 ± 2 .8
4 %
5 .9 ± 3.5Mitral gradient (mm Hg)
! a mild
LA pressure (mm Hg) 16 .4 ± 5.5 17 .8 ± 7 .3 19.9 ± 5.9
2 %1
~ a Modemic TR
Mitral valve area (cm'-) 2 . ± .8 1 .8 ± .6* 1 .6 ± .6*
%
Mean PAP (mm Hg) 27 .4 ± 9.5 3 . ± 11 35 .1 ± 12 .8*
6 12 18
24 3 36 42 48
PVR (dynes-s-cm - ) 211 ± 155 252 ± 181? 362 ± 3 7* Months after procedure
Cardiac output (liters/min) 4.5 ± 1 .2 4.1 ± 1 .2t 3.9 ± 1 .2t
Figure 2 . Kaplan-Meier
318 patients
survival
with mild,
probability
moderate
after balloon
or severe
mitral val-
tricuspid
*p < . 5 versus m ild . tp < . 1 versus mild . Data are presented as mean vuloplasty among
value ± SD . Abbreviations as in Table 3. regurgitation (TR) .
7
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mitral valve gradient) were included in the multivariate model,
tricuspid regurgitation grade remained a significant indepen-
dent predictor of long-term outcome (p < . 5)
. Final mitral
valve area and transmitral pressure gradient emerged as
additional independent predictors of long-term outcome (p <
. 5 for both variables) .
Discussion
Clinical recognition of the presence, etiology and severity of
tricuspid regurgitation associated with mitral stenosis has
assumed increasing importance because it affects the outcome
of mitral valve surgery (3,5,6,7,9,1 ). The degree of resolution
of significant tricuspid regurgitation after correction of mitral
stenosis is not always predictable . Although lesser degrees of
tricuspid regurgitation are likely to diminish after the mitral
lesion is corrected, more severe tricuspid regurgitation may
persist and lead to progressive right ventricular dysfunction
(6,7) . Failure to relieve the severity of tricuspid disease is
believed to seriously compromise the results of mitral valve
operation (6-8). Although still controversial, a common sur-
gical practice is to correct significant residual tricuspid regur-
gitation (by tricuspid valve replacement or annuloplasty) at the
time of mitral valve surgery (6,7,11,12) . The intraoperative
decision to perform tricuspid annuloplasty when deemed nec-
essary has intervened in the course of the disease so that the
impact of significant tricuspid regurgitation on long-term prog-
nosis after mitral valve surgery can now be studied only in
those patients not selected for tricuspid valve repair. Recently,
however, percutaneous mitral balloon valvuloplasty has
emerged as an attractive therapeutic alternative for patients
with mitral stenosis (13,14). Similar to the early surgical
technique of closed valvotomy, it has the potential disadvan-
tage of leaving the associated tricuspid valve disease untreated .
Therefore, patients undergoing balloon mitral valvuloplasty
constitute a unique patient group that can allow us to evaluate
the impact of significant tricuspid regurgitation in mitral
stenosis prospectively and without the selection bias intro-
duced by the surgical decision with regard to tricuspid valve
repair at the time of mitral valve surgery .
No information is available as to whether significant tricus-
pid regurgitation is associated with immediate or late adverse
outcome of balloon mitral valvuloplasty despite the relatively
high prevalence of tricuspid regurgitation in these patients . In
the present study we found that 31% of the patients with mitral
stenosis undergoing balloon mitral valvuloplasty had associ-
ated moderate (19%) or severe (12%) tricuspid regurgitation .
Our results show that patients undergoing balloon mitral
valvuloplasty who have severe tricuspid regurgitation have a
higher rate of suboptimal immediate results and a significantly
poorer event-free survival rate at 4 years of follow-up than that
of patients with mild tricuspid regurgitation (68% vs . 35%, p <
. 1) . Patients with moderate tricuspid regurgitation had an
intermediate risk for suboptimal initial results and adverse late
outcome. Multivariate analysis of the results identified tricus-
pid regurgitation as a strong independent predictor for long-
JACC Vol . 24, No. 3
term event-free survival after balloon mitral valvuloplasty (p <
. 1) .
Preprocedural characteristics . A higher grade of tricuspid
regurgitation was associated with a higher incidence of atrial
fibrillation, moderate mitral regurgitation, symptomatic heart
failure and smaller initial mitral valve area . These findings
show that significant tricuspid regurgitation is associated with
poorer baseline clinical status . Mitral valve score was signifi-
cantly higher in the groups with moderate or severe tricuspid
regurgitation, reflecting more extensive structural and func-
tional disease of the mitral valve apparatus. Increased pulmo-
nary artery pressure and resistance in those with severe
tricuspid regurgitation may Maw to the more advanced mitral
valve disease . The reduced cardiac output can be a conse-
quence of both the increased right ventricular pressure over-
load as well as the hemtrdynamically important tricuspid
regurgitation, which itself can he a consequence of right
ventricular disease . The poorer baseline clinical status in the
group with severe tricuspid regurgitation may reflect a combi-
nation of more advanced mitral disease as well as hemodynam-
ically important pulmonary hypertension, tricuspid regurgita-
tion and right ventricular failure . Consequently, the presence
of significant tricuspid regurgitation identified a subgroup of
patients with advanced mitral, pulmonary vascular and right
ventricular disease . The fact that in the majority of the patients
the tricuspid regurgitation is functional in origin and not due to
intrinsic valve abnormality also supports this view .
Immediate results . Success rate as defined earlier did not
differ significantly among the tricuspid regurgitation groups .
However, patients with moderate or severe tricuspid regurgi-
tation had less optimal results immediately after the proce-
dure. When optimal success rate was defined as final mitral
valve area ? 1 .5 cm 2 without complications (i .e., not including
those with a ?5 % increase but with a final mitral valve area
< 1.5 em 2 ), this optimal success rate was significantly lower for
subjects with moderate or severe than in those with mild
tricuspid regurgitation (69% vs . 62% vs . 51%, respectively, p <
. 1 for severe vs . mild tricuspid regurgitation) . Although
tricuspid regurgitation was a significant univariate predictor of
initial optimal success rate defined in this manner, it was
displaced from a multivariate stepwise regression analysis by
other established predictors of immediate success, such as
mitral valve score, functional class and initial grade of mitral
regurgitation. These data indicate that tricuspid regurgitation
grade is at most a marker for suboptimal initial results because
of its association with higher mitral valve score but cannot
serve as an independent predictor for immediate success rate .
Late outcome . The impact of significant tricuspid regurgi-
tation on late outcome in patients undergoing balloon mitral
valvuloplasty has not been determined to date . The only available
information relating to this question is from follow-up studies of
patients after mitral commissurotomy or replacement . Shafie et
al . (8) followed up 23 patients with variable degrees of tricuspid
regurgitation after closed mitral valvuloplasty and found that
despite successful operation on the mitral valve, eight patients
with initially severe tricuspid regurgitation did not show signifi-
JACC Vol . 24, No. 3
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cant improvement at 1 year of follow-up. Three to five years later
four of these patients underwent repeat catheterization for per-
sistent right ventricular failure and were found to have an
adequate mitral valve area and good left ventricular function but
significant tricuspid regurgitation. King et al . (6) reported high
early and late mortality and poor functional outcome in patients
undergoing late tricuspid valve surgery 4 months to 14 years after
they had had mitral valve replacement without concomitant
correction of tricuspid regurgitation . These investigators (6,8)
recommended tricuspid valve annuloplasty for all patients with
significant tricuspid regurgitation at the time of initial mitral valve
surgery. Recently, Groves et al . (9,1 ) observed reduced exercise
capacity and functional outcome in patients with severe tricuspid
regurgitation after successful mitral valve replacement for rheu-
matic mitral valve disease . They concluded that accurate preop-
erative and intraoperative detection and correction of important
tricuspid regurgitation may best be done during the initial mitral
valve operation. These studies indicate that residual tricuspid
regurgitation is an important determinant of late mortality and
poor functional outcome after mitral valve surgery .
The present finding that patients with severe tricuspid
regurgitation undergoing balloon mitral valvotomy have a
poorer outcome at late follow-up are in accord with the
observations made in patients who underwent mitral valve
surgery for mitral stenosis (6,8,9,1 ). In our patients with
balloon mitral valvuloplasty, the severity of tricuspid regurgi-
tation proved to be an independent marker of late outcome .
This finding also suggests that in addition to being a marker for
a more advanced state of rheumatic mitral disease, tricuspid
regurgitation may itself contribute to a poorer prognosis,
consistent with previous clinical studies in the surgical setting
(6,8-1 ) . Poor late outcome despite an initially successful
balloon mitral valvuloplasty in a large number of patients with
significant tricuspid regurgitation suggests a possible intrinsic
contribution of tricuspid regurgitation to morbidity and mor-
tality in this group .
We can only speculate as to the long-term course of these
patients had they undergone mitral valve surgery and tricuspid
valve annuloplasty or replacement instead of balloon mitral
valvuloplasty. However, the excellent long-term results (free-
dom from symptomatic heart failure and death) (7,11,12)
reported in patients with mitral stenosis undergoing tricuspid
valve repair for significant tricuspid regurgitation during mitral
valve surgery suggest that the surgical approach may be an
alternative option for such patients .
Patients with moderate tricuspid regurgitation had a lower
event-free survival rate than that of patients with mild tricuspid
regurgitation during the first year after the procedure (85% vs .
74%). However, there was no significant difference between
the groups after 4 years of follow-up. This finding may be
related to the natural history of tricuspid regurgitation . Initially
mild tricuspid regurgitation may increase in severity over the
years, changing patients' initially favorable prognosis and
reclassifying them in the group with moderate rather than mild
tricuspid regurgitation. Another explanation may be simply
related to a statistical principle : Regardless of the discrimina-
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tive power of the grading system, intermediate groups will tend
to demonstrate greater variability, rendering them more diffi-
cult to distinguish from the extremes.
Other determinants of late outcome after balloon mitral
valvuloplasty. Previous studies identified predictors of long-
term event-free survival after balloon mitral valvuloplasty to
define the subgroups of patients most likely to benefit from this
procedure (13,14,27,28) . Among the most important predictors
reported are functional class, atrial fibrillation, calcium on
fluoroscopy, mitral valve score, mitral regurgitation and left
ventricular end-diastolic pressure (27-29) . In the present
study, functional class, mitral regurgitation and echocardic-
graphic score were independent predictors for late outcome, a
finding consistent with previous reports (28,29) . We also
identified two additional predictors: previous history of mitral
commissurotomy and degree of tricuspid regurgitation . The
weight of tricuspid regurgitation as a predictor for adverse
outcome was comparable to that of the strongest other predic-
tors.
Study limitations. Although follow-up echocardiography
was not available in all patients, the lack of resolution of
tricuspid regurgitation in patients with significant tricuspid
regurgitation (3 ) supports the possibility that persistent tri-
cuspid regurgitation may contribute to poor outcome . Al-
though we cannot definitely conclude that tricuspitd regurgita-
tion itself is the cause of poor clinical outcome (and not other
unmeasured factors such as right ventricular impairment), it is
at least a significant independent marker for clinical failure
and as such can be used for clinical purposes .
Currently, there is no ideal quantitative method available-
invasive or noninvasive-to measure actual tricuspid regurgi-
tant flow. In addition to the limitations of angiography (31),
invasive grading of tricuspid regurgitation requires positioning
the catheter across the tricuspid valve, thus interfering with
valve competence . Therefore, Doppler echocardiography, es-
pecially when integrating information from both the pulsed
wave and color technique, seems the most appropriate and
readily available tool to assess the severity of tricuspid regur-
gitation (18-2 ). In addition, estimated pulmonary artery
pressure, which can be derived from the tricuspid regurgitation
velocities by continuous wave Doppler echocardiography, may
add to the predictive power of tricuspid regurgitation severity .
The fact that significant prognostic information could be
derived from the Doppler color flow mapping of tricuspid
regurgitation using the grading algorithm described confirms
the usefulness of this noninvasive method . In addition, highly
significant differences in mean right atrial pressure determined
independently at catheterization were found between our mild,
moderate and severe tricuspid regurgitation groups, providing
hemodynamic support for this classification .
Conclusions and clinical implications.
Patients with severe
tricuspid regurgitation undergoing percutaneous balloon mi-
tral valvuloplasty have advanced mitral valve and pulmonary
vascular disease, suboptimal immediate results and poor late
outcome (4-year major event-free probability of 35%)
. These
findings support the surgical data of correcting associated
1 2
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severe tricuspid regurgitation during mitral valve surgery.
Patients with severe tricuspid regurgitation undergoing percu-
tancous balloon mitral valvuloplasty should be followed up
closely with echocardiography. Those patients with persistent
severe tricuspid regurgitation at follow-up might be candidates
for tricuspid valve surgery.
We thank Sujatha Yalivarhy for help in data collection
.
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